Role of atrial peptide system in renal and endocrine adaptation to hypotensive hemorrhage

Brooks Sayre Edwards, R. S. Zimmerman, T. R. Schwab, D. M. Heublein, John C Jr. Burnett

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hypotensive hemorrhage (HH) is characterized by intravascular volume depletion, avid renal sodium retention, and activation of the renin-angiotensin-aldosterone system (RAAS). The current studies were designed to investigate whether intravascular volume depletion would modulate circulating atrial natriuretic factor (ANF) and, further, to examine that contribution, if any, a decrease in ANF would have in mediating the antinatriuresis and RAAS stimulation associated with HH. Two groups of anesthetized dogs underwent controlled arterial hemorrhage to reduce mean arterial pressure by 15-20 mmHg. Data were collected before and immediately after HH. One group (n = 6) underwent hemorrhage alone, whereas a second group (n = 5) underwent HH with simultaneous administration of α-human ANF (2.5 ng·kg -1·min -1), a dose calculated to prevent a reduction in ANF. In the untreated group, circulating ANF was significantly reduced after hemorrhage (79.4 ± 7.4 to 57.2 ± 3.4 pg/ml, P < 0.05), whereas in the treated group ANF increased significantly (73.5 ± 12.2 to 147.4 ± 17.2 pg/ml, P < 0.05). Despite differences in circulating ANF, both groups had similar reductions in urinary sodium excretion and renal blood flow, and similar increases in plasma renin activity. These studies demonstrate that circulating ANF is significantly reduced in HH; however, the mechanisms of antinatriuresis and activation of the RAAS is independent of the reduction in circulating ANF.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume254
Issue number1
StatePublished - 1988

Fingerprint

Atrial Natriuretic Factor
Hemorrhage
Kidney
Renin-Angiotensin System
Sodium
antiarrhythmic peptide
Renal Circulation
Renin
Arterial Pressure
Dogs

ASJC Scopus subject areas

  • Physiology

Cite this

@article{e58be4cbce244f6b933d8f41e1284129,
title = "Role of atrial peptide system in renal and endocrine adaptation to hypotensive hemorrhage",
abstract = "Hypotensive hemorrhage (HH) is characterized by intravascular volume depletion, avid renal sodium retention, and activation of the renin-angiotensin-aldosterone system (RAAS). The current studies were designed to investigate whether intravascular volume depletion would modulate circulating atrial natriuretic factor (ANF) and, further, to examine that contribution, if any, a decrease in ANF would have in mediating the antinatriuresis and RAAS stimulation associated with HH. Two groups of anesthetized dogs underwent controlled arterial hemorrhage to reduce mean arterial pressure by 15-20 mmHg. Data were collected before and immediately after HH. One group (n = 6) underwent hemorrhage alone, whereas a second group (n = 5) underwent HH with simultaneous administration of α-human ANF (2.5 ng·kg -1·min -1), a dose calculated to prevent a reduction in ANF. In the untreated group, circulating ANF was significantly reduced after hemorrhage (79.4 ± 7.4 to 57.2 ± 3.4 pg/ml, P < 0.05), whereas in the treated group ANF increased significantly (73.5 ± 12.2 to 147.4 ± 17.2 pg/ml, P < 0.05). Despite differences in circulating ANF, both groups had similar reductions in urinary sodium excretion and renal blood flow, and similar increases in plasma renin activity. These studies demonstrate that circulating ANF is significantly reduced in HH; however, the mechanisms of antinatriuresis and activation of the RAAS is independent of the reduction in circulating ANF.",
author = "Edwards, {Brooks Sayre} and Zimmerman, {R. S.} and Schwab, {T. R.} and Heublein, {D. M.} and Burnett, {John C Jr.}",
year = "1988",
language = "English (US)",
volume = "254",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Role of atrial peptide system in renal and endocrine adaptation to hypotensive hemorrhage

AU - Edwards, Brooks Sayre

AU - Zimmerman, R. S.

AU - Schwab, T. R.

AU - Heublein, D. M.

AU - Burnett, John C Jr.

PY - 1988

Y1 - 1988

N2 - Hypotensive hemorrhage (HH) is characterized by intravascular volume depletion, avid renal sodium retention, and activation of the renin-angiotensin-aldosterone system (RAAS). The current studies were designed to investigate whether intravascular volume depletion would modulate circulating atrial natriuretic factor (ANF) and, further, to examine that contribution, if any, a decrease in ANF would have in mediating the antinatriuresis and RAAS stimulation associated with HH. Two groups of anesthetized dogs underwent controlled arterial hemorrhage to reduce mean arterial pressure by 15-20 mmHg. Data were collected before and immediately after HH. One group (n = 6) underwent hemorrhage alone, whereas a second group (n = 5) underwent HH with simultaneous administration of α-human ANF (2.5 ng·kg -1·min -1), a dose calculated to prevent a reduction in ANF. In the untreated group, circulating ANF was significantly reduced after hemorrhage (79.4 ± 7.4 to 57.2 ± 3.4 pg/ml, P < 0.05), whereas in the treated group ANF increased significantly (73.5 ± 12.2 to 147.4 ± 17.2 pg/ml, P < 0.05). Despite differences in circulating ANF, both groups had similar reductions in urinary sodium excretion and renal blood flow, and similar increases in plasma renin activity. These studies demonstrate that circulating ANF is significantly reduced in HH; however, the mechanisms of antinatriuresis and activation of the RAAS is independent of the reduction in circulating ANF.

AB - Hypotensive hemorrhage (HH) is characterized by intravascular volume depletion, avid renal sodium retention, and activation of the renin-angiotensin-aldosterone system (RAAS). The current studies were designed to investigate whether intravascular volume depletion would modulate circulating atrial natriuretic factor (ANF) and, further, to examine that contribution, if any, a decrease in ANF would have in mediating the antinatriuresis and RAAS stimulation associated with HH. Two groups of anesthetized dogs underwent controlled arterial hemorrhage to reduce mean arterial pressure by 15-20 mmHg. Data were collected before and immediately after HH. One group (n = 6) underwent hemorrhage alone, whereas a second group (n = 5) underwent HH with simultaneous administration of α-human ANF (2.5 ng·kg -1·min -1), a dose calculated to prevent a reduction in ANF. In the untreated group, circulating ANF was significantly reduced after hemorrhage (79.4 ± 7.4 to 57.2 ± 3.4 pg/ml, P < 0.05), whereas in the treated group ANF increased significantly (73.5 ± 12.2 to 147.4 ± 17.2 pg/ml, P < 0.05). Despite differences in circulating ANF, both groups had similar reductions in urinary sodium excretion and renal blood flow, and similar increases in plasma renin activity. These studies demonstrate that circulating ANF is significantly reduced in HH; however, the mechanisms of antinatriuresis and activation of the RAAS is independent of the reduction in circulating ANF.

UR - http://www.scopus.com/inward/record.url?scp=0023830065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023830065&partnerID=8YFLogxK

M3 - Article

C2 - 2962519

AN - SCOPUS:0023830065

VL - 254

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 1

ER -